2018-06-28T08:58:32-05:00 2017-12-31 EISNERAMPER LLP 750 THIRD AVENUE NEW YORK NY 100172703 990 2017-01-01 364825921 The Mark Foundation for Cancer Research (US) LTD % S PATRICK LEWIS MARK 6468665950 10 EAST 53RD STREET 13TH FLOOR NEW YORK NY 10022 MICHELE CLEARY PHD CEO 6468665950 2018-06-27 true CANDICE METH P01306891 2129498700 2017 2022-09-23 18:48:47Z X MICHELE CLEARY PHD 10 EAST 53RD STREET 13TH FLOOR NEW YORK NY 10022 10550135 false X THEMARKFOUNDATION.ORG X 2015 DE THE MARK FOUNDATION FOR CANCER RESEARCH IS COMMITTED TO ADVANCING BASIC BREAKTHROUGH CANCER RESEARCH, DETECTION, PREVENTION AND CURES FOR CANCER PATIENTS. 2 2 8 0 0 500000 10536000 0 0 0 14135 0 0 500000 10550135 0 3652006 0 0 0 1010561 0 0 35615 290901 770321 290901 5432888 209099 5117247 295811 8121943 86712 2795597 209099 5326346 X THE MISSION OF THE MARK FOUNDATION FOR CANCER RESEARCH (U.S.) LTD. IS TO PROMOTE, ENCOURAGE, AND SUPPORT CHARITIES AND CHARITABLE ENDEAVORS ESTABLISHED FOR THE ADVANCEMENT, PROMOTION AND BENEFIT OF RESEARCH INTO THE CAUSES OF CANCERS IN THE HUMAN BODY, THE DISCOVERY OF CURES FOR SUCH CANCERS, AND THE ALLEVIATION OF THE PAIN AND SUFFERING CAUSED BY SUCH CANCERS. THE FOUNDATION'S goal is to reward cutting-edge, innovative ideas that transform patient care and answer the most complex questions about cancer biology. false false 4324620 3652006 FOUNDATION grants reward innovative thinking that advances the understanding of cancer biology and improves oncology treatment paradigms. THE FOUNDATION supports individual investigators, as well as multidisciplinary collaborative teams conducting research across cancer types. THE grantees become part of THE FOUNDATION'S network of the best scientific minds in cancer research and technological innovation. Grant submissions undergo rigorous peer review by the foundations scientific advisory committee or recommended subject matter experts and are held to the strictest standards of scientific excellence. 4324620 true true false false false false false false false false true true false false true true true false false false false false false false false false false true false true false false false false false false false false false false false false false false false false false true 20 0 true 8 true false false false false false false false false false false X 2 2 true false false false false false false true false false false true true true true true true true true false NY X S PATRICK LEWIS 6468665950 10 EAST 53RD STREET 13TH FLOOR NEW YORK NY 10022 STUART THOMSON DIRECTOR 2.0 0.0 X 0 0 0 STEVEN GAUCI DIRECTOR 2.0 0.0 X 0 0 0 MICHELE CLEARY PHD CHIEF EXECUTIVE OFFICER 40.0 0.0 X 417946 0 108560 S PATRICK LEWIS HEAD OF OPERATIONS AND FINANCE 40.0 0.0 X 98670 0 35814 516616 0 144374 1 false true false KORN FERRY PO BOX 1450 MINNEAPOLIS MN 554855064 RECRUITING SERVICES 143960 ARNOLD PORTER KAYE SCHOLER LLP 601 MASSACHUSETTS AVE NW WASHINGTON DC 200013743 LEGAL SERVICES 106535 2 10536000 10536000 0 14135 14135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10550135 14135 3652006 3652006 0 0 0 516616 215344 287303 13969 0 269250 112234 149738 7278 134000 55855 74521 3624 38898 5362 33536 51797 18306 32031 1460 0 155279 81241 74038 69351 69351 0 0 0 141666 1082 140584 0 22043 2189 19854 52994 7599 45395 0 229874 103221 118208 8445 20549 17953 2596 0 33992 33691 301 0 0 22380 10050 11491 839 1655 1655 PAYROLL PROCESSING FEES 10800 10800 HONORARIUM 6600 6600 OTHER EXPENSES 3138 1887 1251 5432888 4324620 1072653 35615 280838 922265 0 4037511 0 0 0 0 0 0 0 0 0 0 0 0 0 35756 136174 21919 14973 114255 0 0 0 3000001 0 0 0 0 0 12155 295811 8121943 86712 351411 0 2424506 0 0 0 0 0 0 0 0 0 0 0 0 0 19680 86712 2795597 X 209099 5326346 0 0 0 0 209099 5326346 295811 8121943 5117247 X false true X true false X 0 0 0 500000 10536000 11036000 0 0 0 0 0 500000 10536000 11036000 0 11036000 20684 20684 0 0 11056684 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 46171 8978 37193 90003 12941 77062 114255 SERIES B PREFERRED STOCK 3000001 3000001 0 DEFERRED RENT 19680 19680 X 10579560 29425 29425 10550135 10550135 5462313 29425 29425 5432888 5432888 FORM 990, SCHEDULE D, PART X, LINE 2 The Foundation is subject to the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification ("ASC") Topic 740, Income Taxes, relating to the accounting and reporting for uncertainty in income taxes. Because of the Foundation's general tax-exempt status, management believes ASC Topic 740 has not had, and is not expected to have, a material impact on the Foundation's financial statements. true JOHNS HOPKINS UNIVERSITY 733 North Broadway Baltimore MD 21205 520595110 501(C)(3) 3000000 FMV RESEARCH CANCER RESEARCH FUND OF WINCHELL FOUNDATION 55 BROADWAY NEW YORK NY 10006 131933825 501(C)(3) 231000 FMV RESEARCH LIFE SCIENCES RESEARCH FOUNDATION 3520 SAN MARTIN DRIVE BALTIMORE MD 21218 521231801 501(C)(3) 195000 FMV RESEARCH CANCER RESEARCH INSTITUTE 29 BROADWAY NEW YORK NY 10006 131837442 501(C)(3) 175000 FMV RESEARCH PRESAGE BIOSCIENCES INC 530 FAIRVIEW AVENUE SEATTLE WA 98109 263690569 100000 FMV RESEARCH 4 1 FORM 990, SCHEDULE I, PART 1, LINE 2 THE FOUNDATION REQUIRES GRANT RECIPIENTS TO COMPLY WITH STATED TERMS AND CONDITIONS GOVERNING EACH RESEARCH PROGRAM AWARDED, INCLUDING THE SUBMISSION OF PROGRESS REPORTS. DISBURSEMENT OF FUNDS IS CONTINGENT UPON ACCEPTANCE OF THESE TERMS AND TIMELY SUBMISSION OF REPORTS. X X X false false false false false false false false false MICHELE CLEARY PHD CHIEF EXECUTIVE OFFICER 307946 0 110000 0 0 0 107983 0 577 0 526506 0 0 0 FORM 990, SCHEDULE J, PART II, COLUMN B(II) THE CHIEF EXECUTIVE OFFICER IS ENTITLED TO CONTRACTUAL INCENTIVE PAYMENTS AS A PART OF HER EMPLOYMENT AGREEMENT. FORM 990 - AMENDED RETURN THE FOUNDATION HAS AMENDED ITS FORM 990, SCHEDULES A AND B TO AMEND DONOR INFORMATION. FORM 990, PART VI, SECTION A, LINE 2 BOTH MEMBERS OF THE BOARD OF DIRECTORS ARE EMPLOYEES OF PAMPLONA CAPITAL MANAGEMENT LLC. ALEX KNASTER (FOUNDER OF THE MARK FOUNDATION FOR CANCER RESEARCH (U.S.) LTD.) IS THE FOUNDER AND CEO OF PAMPLONA CAPITAL MANAGEMENT LLC. MR. KNASTER DOES NOT HOLD A BOARD SEAT ON THE FOUNDATION'S BOARD. FORM 990, PART VI, SECTION A, LINE 8B GIVEN THE CURRENT SIZE OF THE FOUNDATION'S BOARD OF DIRECTORS, THE FOUNDATION HAS YET TO CREATE COMMITTEES. ALL BUSINESS OF THE FOUNDATION IS CONDUCTED BY THE TWO DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE FOUNDATION'S 990 IS PROVIDED TO THE GOVERNING BODY FOR REVIEW AND COMMENT PRIOR TO ITS ELECTRONIC FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ALL MEMBERS OF THE BOARD OF DIRECTORS AND KEY MEMBERS OF MANAGEMENT ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY AND SIGN IT ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION B, LINE 15A THE CHIEF EXECUTIVE OFFICER WAS HIRED BY THE BOARD OF DIRECTORS IN 2016. AS PART OF HER RECRUITMENT PROCESS, HER COMPENSATION WAS REVIEWED BY THE BOARD USING COMPARABLE MARKET DATA AND THE ASSISTANCE OF AN OUTSIDE RECRUITING FIRM. MS. CLEARY BEGAN WORK IN JANUARY 2017. COMPENSATION OF KEY EMPLOYEES IS DETERMINED BY THE CHIEF EXECUTIVE OFFICER AND APPROVED BY THE BOARD OF DIRECTORS ON AN ANNUAL BASIS, AS PART OF THE FOUNDATION'S BUDGET PROCESS. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S FORM 990 IS AVAILABLE UPON REQUEST. GOVERNING DOCUMENTS ARE ONLY DISTRIBUTED INTERNALLY TO THE BOARD OF DIRECTORS AND MANAGEMENT.